RSS

Max-Planck-Institute for Biophysical Chemistry

A cooperation agreement has been formed between drug discovery-focused contract research organisation (CRO), NovAliX, and a spin-off company of the Max-Planck-Institute for Biophysical Chemistry, ProteoPlex. more

News